FONR
FONAR CORPCompany Information
- Company Name
- FONAR CORP
- CIK
- CIK0000355019
- Category
- Accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- FONR: Nasdaq
- Fiscal Year End
- June 30
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3845
- SIC Description
- Electromedical & Electrotherapeutic Apparatus
- Ticker
- FONR
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-06-02
- Last sale
- —
- Shares purchased (TTM)
- 328,663
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 1
- Shares outstanding
- 6,865,000
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2026-05-11
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | - | - | - | 56 | - | - | - | 56 | - | - | - | 51 | ||||||
| Cash And Cash Equivalents Fair Value Disclosure | 54 | 53 | 54 | - | 54 | 54 | 54 | - | 54 | 53 | 52 | 51 | ||||||
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Current | - | 5 | 5 | 5 | - | - | - | 4 | - | - | - | 4 | ||||||
| Accounts And Other Receivables Net Current | 5 | - | - | - | 5 | 3 | 4 | - | 3 | - | - | - | ||||||
| Accrued Fees And Other Revenue Receivable | 49 | 46 | 45 | 43 | 43 | 42 | 44 | 42 | 41 | - | - | 36 | ||||||
| Inventory Net | - | - | - | 3 | - | - | - | 3 | - | - | - | 3 | ||||||
| Inventory Finished Goods And Work In Process | 3 | 3 | 3 | - | 3 | 3 | 3 | - | 3 | 3 | 3 | 3 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | ||||||
| Assets Current | 148 | 144 | 144 | 145 | 141 | 138 | 139 | 140 | 136 | 133 | 129 | 126 | ||||||
| Deferred Tax Assets Deferred Income | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 8 | 9 | 10 | ||||||
| Property Plant And Equipment Net | 18 | 19 | 19 | 19 | 19 | 19 | 20 | 19 | 19 | 20 | 21 | 22 | ||||||
| Operating Lease Right Of Use Asset | 35 | 36 | 36 | 35 | 36 | 35 | 38 | 38 | 38 | 32 | 33 | 33 | ||||||
| Finance Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Goodwill | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
| Intangible Assets Net Excluding Goodwill | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Other Assets | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | ||||||
| Assets | 219 | 217 | 218 | 217 | 215 | 208 | 212 | 214 | 210 | 202 | 202 | 201 | ||||||
| Long Term Debt Current | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | ||||||
| Other Liabilities Current | 5 | 3 | 5 | 7 | 4 | 4 | 5 | 8 | 5 | 3 | 4 | 5 | ||||||
| Deferred Revenue Current | 4 | 4 | 5 | 5 | 4 | 3 | 4 | 4 | 3 | 4 | 4 | 4 | ||||||
| Operating Lease Liability Current | 4 | 4 | 4 | 3 | 3 | 3 | 4 | 3 | 4 | 5 | 4 | 4 | ||||||
| Finance Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 16 | 14 | 17 | 17 | 14 | 12 | 14 | 18 | 15 | 14 | 14 | 16 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Deferred Revenue Noncurrent | 3 | 4 | 4 | 4 | 4 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | ||||||
| Deferred Income Taxes And Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 35 | 36 | 36 | 35 | 36 | 35 | 37 | 37 | 36 | 30 | 32 | 32 | ||||||
| Finance Lease Liability Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
| Long Term Debt Noncurrent | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Noncurrent | 39 | 40 | 40 | 40 | 41 | 37 | 39 | 40 | 38 | 32 | 33 | 34 | ||||||
| Liabilities | 55 | 54 | 57 | 57 | 55 | 49 | 53 | 57 | 53 | 46 | 47 | 50 | ||||||
| Additional Paid In Capital | 178 | 179 | 179 | 179 | 179 | 179 | 181 | 181 | 181 | 181 | 183 | 183 | ||||||
| Retained Earnings Accumulated Deficit | 1 | -1 | -3 | -5 | -6 | -9 | -10 | -14 | -14 | -16 | -20 | -24 | ||||||
| Treasury Stock Value | -0 | -1 | -1 | -1 | -1 | -0 | -1 | -1 | -0 | -0 | -1 | -1 | ||||||
| Stockholders Equity | 164 | 163 | 175 | 173 | 172 | 159 | 159 | 166 | 157 | 156 | 154 | 151 | ||||||
| Minority Interest | -14 | -14 | -13 | -13 | -12 | -11 | -10 | -9 | -9 | -8 | -7 | -7 | ||||||
| Liabilities And Stockholders Equity | 219 | 217 | 218 | 217 | 215 | 208 | 212 | 214 | 210 | 202 | 202 | 201 | ||||||
| Allowance For Doubtful Accounts Premiums And Other Receivables | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | - | 0 | ||||||
| Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialFONAR CORP (FONR) — SEC Financial Statements & Analysis
FONAR CORP (FONR) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. FONAR CORP trades on Nasdaq as: FONR. FONAR CORP (FONR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-11. Based on that filing, On profitability, FONAR CORP posts a gross margin of 100.07%, an operating margin of 10.80%, a net margin of 11.65%, a Return on Equity (ROE) of 7.30%, a Return on Assets (ROA) of 5.66%, and a Return on Invested Capital (ROIC) of 10.29%. Per share, it reports EPS of $1.79, diluted EPS of $1.95, free cash flow per share of $0.67, and a dividend per share of $0.68. Over the trailing year, it posted revenue growth of 2.25% year-over-year, net income growth of 0.62% year-over-year, and EPS growth of 0.62% year-over-year. On the balance sheet, it maintains a current ratio of 9.18x, a quick ratio of 9.09x, working capital of $131.88M, a debt-to-equity ratio of 0.33x, a debt ratio of 0.25, an interest coverage ratio of 1078.17x, free cash flow of $4.58M (TTM), and net debt of $-53.43M. Figures sourced from SEC EDGAR.
- EPS TTM
- $1.79
- ROE TTM
- 7.30%
- ROA TTM
- 5.66%
- Debt To Equity
- 0.33x
- Free Cash Flow TTM
- $4.58M
- Net Revenue TTM Growth 1Y
- 2.25%
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is FONAR CORP in?
FONAR CORP (FONR) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What exchange does FONR trade on?
FONAR CORP (FONR) trades on the Nasdaq.
Where is FONAR CORP incorporated?
FONAR CORP is incorporated in DE.
When was FONAR CORP (FONR)'s most recent SEC filing?
FONAR CORP (FONR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-11.
What is FONR's EPS (earnings per share)?
FONAR CORP (FONR)'s trailing twelve month EPS is $1.79 as of 2026-03-31.
What is FONR's ROE (return on equity)?
FONAR CORP (FONR)'s trailing twelve month Return on Equity (ROE) is 7.30% as of 2026-03-31.
What is FONR's ROA (return on assets)?
FONAR CORP (FONR)'s trailing twelve month Return on Assets (ROA) is 5.66% as of 2026-03-31.
What is FONR's ROIC (return on invested capital)?
FONAR CORP (FONR)'s trailing twelve month Return on Invested Capital (ROIC) is 10.29% as of 2026-03-31.